United States · 
Who invested in Ampersand Biomedicines?
Ampersand Biomedicines's investors include Eli Lilly and Flagship Pioneering.
United States · Series B startup
Who invested in Ampersand Biomedicines
Funding summaryUpdated 26 Oct 2026
$65Mraised across 1 round since 2025, from 1 source
- Latest round
- Series B, $65MMar 2025
- Investors
- 2
The rounds
- Mar 2025
Founders and team
From Ampersand Biomedicines's own website: 2 on the team.
- Melanie Morel-FerrisVice President, Finance
- Elizabeth MilyDirector
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Ampersand Biomedicines
How much has Ampersand Biomedicines raised?
Ampersand Biomedicines has raised $65M across 1 round since 2025.
When did Ampersand Biomedicines last raise?
Ampersand Biomedicines's most recent round was a Series B of $65M in Mar 2025.
What was Ampersand Biomedicines's biggest round?
Its most recent round, $65M in Mar 2025, is also its largest on record.
Who backed Ampersand Biomedicines first?
Ampersand Biomedicines's first round on record, in Mar 2025, was backed by Eli Lilly and Flagship Pioneering.
What stage is Ampersand Biomedicines at?
Ampersand Biomedicines's latest named round is a Series B, in Mar 2025.
Where is Ampersand Biomedicines based?
Ampersand Biomedicines is based in the United States.
Companies like Ampersand Biomedicines
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.